Health Enhancement Products Signs Contract With Specialty Nutrition Group, Inc. for Re-Branding and Product Marketing of ProAlgaZyme
Greg Horn, Past CEO of General Nutrition Centers (GNC), to Head up Project
SCOTTSDALE, AZ--(Marketwire - December 13, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI) announced today that they have entered into a re-branding and
marketing agreement with Specialty Nutrition Group, Inc. (SNG) Florida. The
agreement calls for SNG to "create a new brand positioning," including
packaging and marketing materials, and to identify and develop potential
partners for distribution.
A spokesman for HEPI stated: "For the past 3 1/2 years we've been working
diligently to prove the efficacy of our product, and although we've done
some marketing of ProAlgaZyme, it's been minimal at best and not as
successful as we had hoped. With the recent peer reviewed publication with
respect to the results of our Cameroon trials, ProAlgaZyme's credibility as
a nutraceutical should be greatly enhanced. We believe that the
nutraceutical industry will take a more serious look at the sales potential
of a product whose claimed benefits are supported by a peer reviewed study,
particularly compared to other products whose claimed benefits are not
supported by a clinical study. Specialty Nutrition Group, Inc. is the
premier marketing and branding group in this industry and we're thrilled
that they are working with us on this exciting project."
Specialty Nutrition Group, Inc. is a nutrition brand building firm focused
on commercializing innovative and scientifically validated nutrition
products. SNG acts as co-development partner with large consumer products
and nutrition companies to rapidly commercialize nutrition innovations,
represents academic institutions and individual inventors to find new
commercial applications for their inventions, and develops its own brands
for commercial launch in the nutraceutical market. The professionals of
Specialty Nutrition Group, Inc. have been responsible for launching new
nutraceuticals products with current annual retail sales of over $1
billion.
The Group's primary partners are Greg Horn, former CEO of General Nutrition
Centers, (GNC), where he was responsible for building GNC from $400 million
to $1.5 billion in revenues. Irina Lorenzi, President of SNG and past VP of
Marketing at Rexall-Sundown where she was responsible for multiple
supplement lines.
Irina Lorenzi, President of SNG stated: "We see significant health and
commercial potential for the ProAlgaZyme formulation," and we are delighted
to play a role in achieving that potential." Greg Horn, Principal at SNG
noted: "This product offers the rare combination of proprietary
manufacturing, intellectual property, and clinical research on the final
product, which has the benefit of being all natural. The early research
indicates effectiveness against a cluster of health issues with tens of
millions of suffers in the U.S. alone, an indicator of strong market
potential."
PRINCIPALS IN Specialty Nutrition Group, Inc. ARE AS FOLLOWS:
Irina Lorenzi President of SNG is a leading innovator and brand builder in
the health and nutrition category. Her 20-year career spans every aspect of
marketing, product development, merchandising and brand management across
all retail channels. Her early career was spent as a merchandiser and lead
buyer for natural foods retailers, including Nature Food Centres and
Alfalfa's Market. She then served as project manager with responsibility
for the development and launch of the Nature's Fresh! Northwest lifestyle
superstore, a fully branded innovative natural foods store incorporating a
wellness education center, an integrative pharmacy and a spa in one 36,000
square-foot retail space. The Nature's store was widely acclaimed both
within and outside the industry, winning the national award for retail
store of the year (all categories) in 1998. Irina then served as brand
director for the launch and marketing of PharmAssure, a co-brand developed
as part of the GNC and Rite Aid joint venture. She was then appointed
senior sales director for the vitamin, mineral and specialty supplements
category at General Nutrition Center, the world's largest specialty
retailer, with responsibility for approximately a third of GNC's revenue.
Irina was responsible as Vice President of Marketing for Rexall-Sundown
supplement lines, including Osteo Bi-Flex, Rexall, Sundown and Sundown
Kids. Most recently, she was Vice President of Innovation and Supply Chain
for Garden of Life during a successful 18-month turnaround.
Greg Horn has dedicated his career to building brands that enhance healthy
living. He was Chief Executive Officer of General Nutrition Centers, Inc.,
a $1.5 billion NASDAQ-traded company. He held a number of positions with
GNC, including head of marketing and business development and chief
operating officer before becoming CEO and was instrumental in building the
GNC brand and in expanding the company by $100 million per year 11 years in
a row, from $400 million to $1.5 billion in revenues. When GNC was acquired
in 1999 by Royal Numico, he was chairman of Royal Numico's North American
Executive Committee, overseeing all the company's $2.5 billion specialty
retail, mass market, and direct selling operations on this continent. He is
founder and CEO of Specialty Nutrition Group (SNG), a leading innovator in
the nutrition brand building from concept through launch. He has also
served as an advisor or board member to several health-oriented companies,
including Garden of Life, PacificHealth Laboratories, Brand New Brands,
Efficas, and Know Fat Franchising. He holds an MBA from UCLA and a BA
(summa cum laude, phi beta kappa) from the University of Redlands.
About Health Enhancement Products, Inc. and ProAlgaZyme
Health Enhancement Products Inc. is a nutraceutical company engaged in the
development of a Dietary Supplement product using only pure, all-natural
ingredients. The company's sole product is ProAlgaZyme, a liquid product
produced from algae grown in 100% distilled water. The liquid in which the
algae are grown is drawn off, filtered, tested and bottled as ProAlgaZyme.
Except for any historical information, the matters discussed in this press
release contain forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. These forward-looking statements involve risks and
uncertainties. A number of factors could cause actual results to differ
from those indicated in the forward-looking statements, including the
timing of completion of a trial, actual future clinical trial results being
different than the results the company has obtained to date, and the
company's ability to secure funding. Such statements are subject to a
number of assumptions, risks and uncertainties. Readers are cautioned that
such statements are not guarantees of future performance and that actual
results or developments may differ materially from those set forth in the
forward-looking statements. The company undertakes no obligation to
publicly update or revise forward-looking statements, whether as a result
of new information or otherwise.
Contact Information: For more information, please visit www.heponline.com.
Contact information:
John Gorman
Email Contact:
480-385-3800